• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发展中国家的胎儿唐氏综合征筛查模型;第一部分:母体血清筛查的性能。

Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening.

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.

出版信息

BMC Health Serv Res. 2019 Nov 27;19(1):897. doi: 10.1186/s12913-019-4446-x.

DOI:10.1186/s12913-019-4446-x
PMID:31775842
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6880541/
Abstract

BACKGROUND

To identify the performance of fetal Down syndrome (DS) screening for developing countries.

METHODS

A prospective study on MSS (maternal serum screening) with complete follow-ups (n = 41,924) was conducted in 32 network hospitals in the northern part of Thailand. Various models of MSS were tested for performance.

RESULTS

MSS based on Caucasian reference range resulted in very high false positive rate (FPR; 13%) in our country, compared to the rate of 7.8% with our own (Thai) reference range, whereas the detection rate was comparable. As individual screening, C-S (contingent first trimester screening including PAPP-A, and free beta-hCG, classified as a) high risk [> 1:30], indicated for invasive diagnosis; b) intermediate risk [1:30-1500], indicated for STS; and c) low risk [< 1:1500], need no further tests.) was the most effective model (sensitivity 84.9%, FPR 7.7%) but nearly one-third needed the second trimester test (STS) because of intermediate results. Additionally, about one-third had their first visits in the second trimester and had no chance of FTS (first trimester screening). C-S plus STS had a sensitivity of 82.4% and FPR 8.1% whereas independent first and second trimester screening model (I-S) gave the sensitivity of 78.4% and FPR of 7.5% but was much more convenient and practical.

CONCLUSION

C-S plus STS was the most effective models while I-S model was also effective and may be better for developing countries because of its simplicity and feasibility.

摘要

背景

旨在确定胎儿唐氏综合征(DS)筛查在发展中国家的表现。

方法

在泰国北部的 32 家网络医院进行了一项前瞻性的 MSS(母体血清筛查)研究,对其进行了完整的随访(n=41924)。测试了各种 MSS 模型的性能。

结果

基于白种人参考范围的 MSS 在我国产生了非常高的假阳性率(FPR;13%),而使用我们自己(泰国)的参考范围时,该比率为 7.8%,但检测率相当。作为个体筛查,C-S(包括妊娠相关血浆蛋白 A 和游离β-hCG 的 contingent 早期筛查,分为 a)高风险[>1:30],需要进行侵入性诊断;b)中风险[1:30-1500],需要进行 STS;c)低风险[<1:1500],无需进一步检测。)是最有效的模型(敏感性 84.9%,FPR 7.7%),但近三分之一的患者需要进行中孕期检测(STS),因为结果为中风险。此外,大约三分之一的患者在中孕期首次就诊,没有机会进行 FTS(早孕期筛查)。C-S 加 STS 的敏感性为 82.4%,FPR 为 8.1%,而独立的早孕期和中孕期筛查模型(I-S)的敏感性为 78.4%,FPR 为 7.5%,但更方便和实用。

结论

C-S 加 STS 是最有效的模型,而 I-S 模型也很有效,对于发展中国家可能更好,因为其简单性和可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d620/6880541/73e389f73aed/12913_2019_4446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d620/6880541/73e389f73aed/12913_2019_4446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d620/6880541/73e389f73aed/12913_2019_4446_Fig1_HTML.jpg

相似文献

1
Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening.发展中国家的胎儿唐氏综合征筛查模型;第一部分:母体血清筛查的性能。
BMC Health Serv Res. 2019 Nov 27;19(1):897. doi: 10.1186/s12913-019-4446-x.
2
Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis.发展中国家的唐氏综合征胎儿筛查模型;第二部分:成本效益分析。
BMC Health Serv Res. 2019 Nov 27;19(1):898. doi: 10.1186/s12913-019-4699-4.
3
First- and second-trimester evaluation of risk for Down syndrome.孕早期和孕中期唐氏综合征风险评估
Obstet Gynecol. 2007 Jul;110(1):10-7. doi: 10.1097/01.AOG.0000263470.89007.e3.
4
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
5
Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions.唐氏综合征产前筛查的进展:II. 孕早期检测、综合检测及未来方向。
Clin Chim Acta. 2002 Oct;324(1-2):1-11. doi: 10.1016/s0009-8981(02)00187-0.
6
[Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].高龄孕妇孕中期血清学筛查唐氏综合征:一项多中心前瞻性研究
Zhonghua Fu Chan Ke Za Zhi. 2008 Oct;43(10):737-41.
7
Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.在丹麦临床环境中使用游离胎儿 DNA 进行有条件的早孕期筛查非整倍体。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):470-479. doi: 10.1002/uog.17562. Epub 2018 Mar 4.
8
Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.跨孕期重复测量唐氏综合征筛查检测:评估。
Health Technol Assess. 2010 Jul;14(33):1-80. doi: 10.3310/hta14330.
9
[MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].[母体血清筛查试验中游离胎儿DNA临床应用模型分析]
Akush Ginekol (Sofiia). 2015;54(7):15-21.
10
ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.ADAM 12作为孕早期母体血清标志物用于唐氏综合征筛查。
Prenat Diagn. 2006 Oct;26(10):973-9. doi: 10.1002/pd.1540.

引用本文的文献

1
Down syndrome burden in China and globally: a comparative analysis of 1990-2021 trends and future projections based on GBD 2021 database.中国和全球的唐氏综合征负担:基于全球疾病负担研究(GBD)2021数据库对1990 - 2021年趋势及未来预测的比较分析
Front Public Health. 2025 Aug 11;13:1632250. doi: 10.3389/fpubh.2025.1632250. eCollection 2025.
2
Effectiveness of Fetal Medicine Foundation's Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11-13 weeks of Gestation: 12 Years' Experience in Northern Thailand.胎儿医学基金会非生化风险计算算法在孕11至13周常见三体筛查中的有效性:泰国北部的12年经验
Int J Womens Health. 2025 Jun 5;17:1693-1699. doi: 10.2147/IJWH.S526271. eCollection 2025.
3

本文引用的文献

1
False positive rate of serum markers for Down syndrome screening: does transportation have any effect?唐氏综合征筛查血清标志物的假阳性率:运输会有影响吗?
J Med Assoc Thai. 2012 Feb;95(2):152-5.
2
Different median levels of serum triple markers in the second trimester of pregnancy in a Thai Ethnic Group.泰国某民族妊娠中期血清三联标志物的不同中位数水平。
J Obstet Gynaecol Res. 2012 Apr;38(4):686-91. doi: 10.1111/j.1447-0756.2011.01769.x. Epub 2012 Mar 2.
3
Median levels of serum biomarkers of fetal Down syndrome detected during the first trimester among pregnant Thai women.
Down Syndrome Screening among Pregnant Women Visiting the Department of Obstetrics and Gynaecology of a Tertiary Care Centre.
唐氏综合征筛查在妇产科就诊孕妇中的应用。
JNMA J Nepal Med Assoc. 2023 Oct 1;61(266):807-810. doi: 10.31729/jnma.8293.
4
Effects of an animated educational video on knowledge of cell-free DNA screening among Thai pregnant women: a randomized control trial.动画教育视频对泰国孕妇细胞游离 DNA 筛查知识的影响:一项随机对照试验。
BMC Pregnancy Childbirth. 2023 Dec 11;23(1):853. doi: 10.1186/s12884-023-06170-8.
5
Economic evaluation of prenatal screening for fetal aneuploidies in Thailand.泰国胎儿非整倍体产前筛查的经济评价。
PLoS One. 2023 Sep 15;18(9):e0291622. doi: 10.1371/journal.pone.0291622. eCollection 2023.
6
Performance of Serum Quad Test in Screening for Fetal Down Syndrome in a Large-Scale Unselected Population in a Developing Country.大规模未选择人群中在发展中国家使用血清四联检测筛查胎儿唐氏综合征的性能。
Int J Public Health. 2023 Apr 5;68:1605441. doi: 10.3389/ijph.2023.1605441. eCollection 2023.
7
Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand.泰国一家三级医院的产前筛查检测与胎儿非整倍体的流行率。
PLoS One. 2023 Apr 20;18(4):e0284829. doi: 10.1371/journal.pone.0284829. eCollection 2023.
8
Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.母体外周血甲胎蛋白标志物在中孕期唐氏综合征 21 三体和 18 三体筛查中的诊断价值。
Sci Rep. 2022 Aug 10;12(1):13605. doi: 10.1038/s41598-022-16807-x.
9
Ethnicity-Specific Normative Models of Quadruple Test as a Screening Test for Down Syndrome.种族特异性四联筛查试验作为唐氏综合征筛查试验的规范模型。
Medicina (Kaunas). 2021 Jun 24;57(7):651. doi: 10.3390/medicina57070651.
10
The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome.载脂蛋白E检测在胎儿唐氏综合征筛查中的意义
J Clin Med. 2020 Dec 10;9(12):3995. doi: 10.3390/jcm9123995.
泰国孕妇孕早期胎儿唐氏综合征血清生物标志物的中位数水平。
Int J Gynaecol Obstet. 2012 May;117(2):140-3. doi: 10.1016/j.ijgo.2011.11.026. Epub 2012 Feb 25.
4
Performance characteristics of the UniCel DxI 800 immunoassay for the maternal serum quadruple test, including median values for each week of gestation, in Korean women.韩国女性中用于母血清四联筛查的UniCel DxI 800免疫测定法的性能特征,包括妊娠各周的中位数。
Korean J Lab Med. 2010 Apr;30(2):126-32. doi: 10.3343/kjlm.2010.30.2.126.
5
First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.通过游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白A进行孕早期21三体综合征筛查:孕妇及妊娠特征的影响
Ultrasound Obstet Gynecol. 2008 May;31(5):493-502. doi: 10.1002/uog.5332.
6
Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.合艾地区医院对唐氏综合征胎儿进行三联标志物血清筛查的经验。
J Med Assoc Thai. 2007 Oct;90(10):1970-6.
7
Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.沙特孕妇孕10至13(+6)周时母体血清游离β-绒毛膜促性腺激素、妊娠相关血浆蛋白-A与胎儿颈部半透明层厚度与协变量的关系
Prenat Diagn. 2007 Apr;27(4):303-11. doi: 10.1002/pd.1661.
8
Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations.孕中期唐氏综合征二联或三联筛查:中国人群与高加索人群的比较
Int J Gynaecol Obstet. 2006 Jul;94(1):67-72. doi: 10.1016/j.ijgo.2006.04.030. Epub 2006 Jun 23.
9
Higher median levels of free beta-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population.中国人群孕期头三个月游离β-人绒毛膜促性腺激素(free beta-hCG)和妊娠相关血浆蛋白A(PAPP-A)的中位数水平较高。对中国人群唐氏综合征孕早期联合筛查的启示。
Fetal Diagn Ther. 2006;21(1):140-3. doi: 10.1159/000089064.
10
First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).孕早期和孕中期唐氏综合征产前筛查:血清、尿液及超声筛查研究(SURUSS)结果
J Med Screen. 2003;10(2):56-104. doi: 10.1258/096914103321824133.